Neuropsychological outcomes from a randomized trial of triple intrathecal chemotherapy compared with 18 Gy cranial radiation as CNS treatment in acute lymphoblastic leukemia: Findings from Dana-Farber Cancer Institute ALL Consortium Protocol 95-01

Journal of Clinical Oncology

Volumn 25, Issue 31, 2007, Pages 4914-4921

  Waber, Deborah P ^a   Turek, Jennifer ^b   Catania, Lori ^b   Stevenson, Kristen ^b   Robaey, Philippe ^b   Romero, Ivonne ^b   Adams, Heather ^b   Alyman, Cheryl ^b   Jandet Brunet, Christine ^b   Neuberg, Donna S ^b   Sallan, Stephen E ^b   Silverman, Lewis B ^b  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ASPARAGINASE; CYTARABINE; DOXORUBICIN; FOLINIC ACID; HYDROCORTISONE; MERCAPTOPURINE; METHOTREXATE; PREDNISONE; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ARTICLE; BRAIN RADIATION; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CENTRAL NERVOUS SYSTEM; CHILD; CLINICAL TRIAL; COGNITION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; INTELLIGENCE QUOTIENT; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MEMORY; MULTIPLE CYCLE TREATMENT; NEUROPSYCHOLOGICAL TEST; NEUROTOXICITY; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; RANDOMIZED CONTROLLED TRIAL; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CENTRAL NERVOUS SYSTEM DISEASES; CENTRAL NERVOUS SYSTEM NEOPLASMS; CHILD; CHILD, PRESCHOOL; CRANIAL IRRADIATION; CYTARABINE; FEMALE; GLUCOCORTICOIDS; HUMANS; HYDROCORTISONE; INFANT; INJECTIONS, SPINAL; MALE; METHOTREXATE; NEUROPSYCHOLOGICAL TESTS; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA;

EID: 36849056160     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2007.10.8464     Document Type: Article

References (37)

1. Anderson VA, Godber T, Smibert E, et al: Cognitive and academic outcome following cranial irradiation and chemotherapy in children: A longitudinal study. Br J Cancer 82:255-262, 2000
2. Jankovic M, Brouwers P, Valsecchi MG, et al: Association of 1800 cGy cranial irradiation with intellectual function in children with acute lymphoblastic leukaemia: ISPACC. International Study Group on Psychosocial Aspects of Childhood Cancer. Lancet 344:224-227, 1994
3. Langer T, Martus P, Ottensmeier H, et al: CNS late-effects after ALL therapy in childhood: Part III: Neuropsychological performance in long-term survivors of childhood ALL: Impairments of concentration, attention, and memory. Med Pediatr Oncol 38:320-328, 2002
4. MacLean WE Jr, Noll RB, Stehbens JA, et al: Neuropsychological effects of cranial irradiation in young children with acute lymphoblastic leukemia 9 months after diagnosis: The Children's Cancer Group. Arch Neurol 52:156-160, 1995
5. Hill JM, Kornblith AB, Jones D, et al: A comparative study of the long term psychosocial functioning of childhood acute lymphoblastic leukemia survivors treated by intrathecal methotrexate with or without cranial radiation. Cancer 82:208-218, 1998
6. Rowland JH, Glidewell OJ, Sibley RF, et al: Effects of different forms of central nervous system prophylaxis on neuropsychologic function in childhood leukemia. J Clin Oncol 2:1327-1335, 1984
7. Stehbens JA, MacLean WE, Kaleita TA, et al: Effects of CNS prophylaxis on the neuropsychological performance of children with acute lymphoblastic leukemia: nine months postdiagnosis. Children's Health Care 23:231, 1994
8. Spiegler BJ, Kennedy K, Maze R, et al: Comparison of long-term neurocognitive outcomes in young children with acute lymphoblastic leukemia treated with cranial radiation or high-dose or very high-dose intravenous methotrexate. J Clin Oncol 24:3858-3864, 2006
9. Mulhern RK, Wasserman AL, Fairclough D, et al: Memory function in disease-free survivors of childhood acute lymphoblastic leukemia given CNS prophylaxis with or without 1,800 cGy cranial irradiation. J Clin Oncol 6:315-320, 1988
10. Mulhern RK, Fairclough D, Ochs J: A prospective comparison of neuropsychologic performance of children surviving leukemia who received 18-Gy, 24-Gy, or no cranial irradiation. J Clin Oncol 9:1348-1356, 1991
11. Kahkonen M, Metsahonkala L, Minn H, et al: Cerebral glucose metabolism in survivors of childhood acute lymphoblastic leukemia. Cancer 88:693-700, 2000
12. Freeman AI, Boyett JM, Glicksman AS, et al: Intermediate-dose methotrexate versus cranial irradiation in childhood acute lymphoblastic leukemia: A ten-year follow-up. Med Pediatr Oncol 28:98-107, 1997
13. Tubergen DG, Gilchrist GS, O'Brien RT, et al: Prevention of CNS disease in intermediate-risk acute lymphoblastic leukemia: Comparison of cranial radiation and intrathecal methotrexate and the importance of systemic therapy: A Childrens Cancer Group report. J Clin Oncol 11:520-526, 1993
14. Moghrabi A, Levy DE, Asselin B, et al: Results of the Dana-Farber Cancer Institute ALL Consortium Protocol 95-01 for children with acute lymphoblastic leukemia. Blood 109:896-904, 2007
15. Silverman LB, Gelber RD, Dalton VK, et al: Improved outcome for children with acute lymphoblastic leukemia: Results of Dana-Farber Consortium Protocol 91-01. Blood 97:1211-1218, 2001
16. Wechsler D: Wechsler Intelligence Scale for Children (ed 3). New York, NY, Psychological Corporation, 1991
17. Wechsler D: Wechsler Adult Intelligence Scale (ed 3). San Antonio, TX, Psychological Corporation, 1997
18. Hollander M, Wolfe DA: Nonparametric Statistical Inference. New York, NY, John Wiley & Sons, 1973
19. Waber DP, Wolff PH, Forbes PW, et al: Rapid automatized naming in children referred for evaluation of heterogeneous learning problems: How specific are naming speed deficits to reading disability? Child Neuropsychology 6:251-261, 2000
20. Waber DP, Shapiro BL, Carpentieri SC, et al: Excellent therapeutic efficacy and minimal late neurotoxicity in children treated with 18 grays of cranial radiation therapy for high-risk acute lymphoblastic leukemia: A 7-year follow-up study of the Dana-Farber Cancer Institute Consortium Protocol 87-01. Cancer 92:15-22, 2001
21. Waber DP, Carpentieri SC, Klar N, et al: Cognitive sequelae in children treated for acute lymphoblastic leukemia with dexamethasone or prednisone. J Pediatr Hematol Oncol 22:206-213, 2000
22. Waber DP, Tarbell NJ, Fairclough D, et al: Cognitive sequelae of treatment in childhood acute lymphoblastic leukemia: Cranial radiation requires an accomplice. J Clin Oncol 13:2490-2496, 1995
23. Waber DP, Silverman LB, Catania L, et al: Outcomes of a randomized trial of hyperfractonated cranial radiation therapy (18 Gy) for treatment of high-risk acute lymphoblastic leukemia: Therapeutic efficacy and neurotoxicity. J Clin Oncol 22:2701-2707, 2004
24. Precourt S, Robaey P, Lamothe I, et al: Verbal cognitive functioning and learning in girls treated for acute lymphoblastic leukemia by chemotherapy with or without cranial irradiation. Developmental Neuropsychology 21:173-195, 2002
25. Raymond-Speden E, Tripp G, Lawrence B, et al: Intellectual, neuropsychological, and academic functioning in long-term survivors of leukemia. J Pediatr Psychol 25:59-68, 2000
26. Waber DP, Gioia G, Paccia J, et al: Sex differences in cognitive processing in children treated with CNS prophylaxis for acute lymphoblastic leukemia. J Pediatr Psychol 15:105-122, 1990
27. Moleski M: Neuropsychological, neuroanatomical, and neurophysiological consequences of CNS chemotherapy for acute lymphoblastic leukemia. Archives of Clinical Neuropsychology 15:603-630, 2000
28. Robison LL, Nesbit ME Jr, Sather HN, et al: Factors associated with IQ scores in long-term survivors of childhood acute lymphoblastic leukemia. Amer J Ped Hematol/Oncol 6:115-121, 1984
29. Mullenix PJ, Kernan WJ, Schunior A, et al: Interactions of steroid, methotrexate, and radiation determine neurotoxicity in an animal model to study therapy for childhood leukemia. Pediatr Res 35:171-178, 1994
30. Monje ML, Toda H, Palmer TD: Inflammatory blockade restores adult hippocampal neurogenesis. Science 302:1760-1765, 2003
31. Balsom WR, Bleyer WA, Robison LL, et al: Intellectual function in long-term survivors of childhood acute lymphoblastic leukemia: Protective effect of pre-irradiation methotrexate? A Childrens Cancer Study Group study. Med Pediatr Oncol 19:486-492, 1991
32. Geyer JR, Taylor EM, Milstein JM, et al: Radiation, methotrexate, and white matter necrosis: Laboratory evidence for neural radioprotection with preirradiation methotrexate. Int J Radiat Oncol Biol Phys 15:373-375, 1988
33. Montour-Proulx I, Kuehn SM, Keene DL, et al: Cognitive changes in children treated for acute lymphoblastic leukemia with chemotherapy only according to the Pediatric Oncology Group 9605 protocol. J Child Neurol 20:129-133, 2005
34. Khong P-L, Leung LHT, Fung ASM, et al: White matter anisotropy in post-treatment childhood cancer survivors: Preliminary evidence of association with neurocognitive function. J Clin Oncol 24:884-890, 2006
35. Reddick WE, Shan ZY, Glass JO, et al: Smaller white-matter volumes are associated with larger deficits in attention and learning among long-term survivors of acute lymphoblastic leukemia. Cancer 106:941-949, 2006
36. Krajinovic M, Robaey P, Chiasson S, et al: Polymorphisms of genes controlling homocysteine levels and IQ score following the treatment for childhood ALL. Pharmacogenomics 6:293-302, 2005
37. Pui C-H, Cheng C, Leung W, et al: Extended follow-up of long-term survivors of childhood acute lymphoblastic leukemia. New Engl J Med 349:640-649, 2003